緑内障市場レポート：2030年までの動向、予測、競合分析

緑内障の動向と予測

世界の緑内障市場は、2024年から2030年までのCAGR 7.0%で、2030年までに推定120億4,000万米ドルに達すると予想されています。この市場の主な促進要因は、緑内障罹患率の増加、緑内障に対する意識の高まり、眼科分野における新たな治療戦略に対するニーズの高まりです。世界の緑内障市場の将来は、病院薬局、小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。

緑内障市場に関する洞察

Lucintelは、睡眠時無呼吸症候群、血管疾患、かすみ目などの加齢に伴う眼疾患の有病率の上昇により、開放隅角緑内障が予測期間中に最も高い成長を遂げると予測しています。

アジア太平洋地域は、診断、治療、新薬の投与の進歩により、予測期間中に最も高い成長が見込まれる

よくある質問

Q.1緑内障の市場規模はどれくらいですか：

A1.世界の緑内障市場は、2030年までに推定120億4,000万米ドルに達すると予想されています。

Q.2緑内障市場の成長予測は：

A2.世界の緑内障市場は、2024年から2030年にかけて7.0%のCAGRで成長すると予想されています。

Q.3緑内障市場の成長に影響を与える主な要因は何ですか：

A3.この市場の主な促進要因は、緑内障の罹患率の増加、緑内障に対する認識の高まり、および眼科分野における新たな治療戦略に対するニーズの高まりです。

Q4.市場の主要セグメントは：

A4.緑内障市場の将来は、病院薬局、小売薬局、オンライン薬局市場にチャンスがあり、有望に見えます。

Q5.市場の主要企業は：

A5.主要な緑内障企業は以下のとおりです。

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch+Lomb Corporation
• Teva Pharmaceuticals Industries
• 0

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、睡眠時無呼吸症候群、血管疾患、かすみ目などの加齢に伴う眼疾患の有病率の上昇により、開放隅角緑内障が予測期間中に最も高い成長を遂げると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.アジア太平洋地域は、診断、治療、新薬の投与の進歩により、予測期間中に最も高い成長が見込まれると予想されます。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の緑内障市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の緑内障市場動向（2018-2023）と予測（2024-2030）
• 疾患の種類別の世界の緑内障市場
  • 開放隅角緑内障
  • 閉塞隅角緑内障
  • その他
• 薬剤クラス別の世界の緑内障市場
  • プロスタグランジン類縁体
  • ベータブロッカー
  • アドレナリン作動薬
  • 炭酸脱水酵素阻害剤
  • その他
• 流通チャネル別の世界の緑内障市場
  • 病院薬局
  • 小売薬局
  • オンライン薬局

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の緑内障市場
• 北米の緑内障市場
• 欧州の緑内障市場
• アジア太平洋の緑内障市場
• その他地域の緑内障市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

• 成長機会分析
  • 疾患の種類別の世界の緑内障市場の成長機会
  • 薬剤クラス別の世界緑内障市場の成長機会
  • 流通チャネル別の世界緑内障市場の成長機会
  • 地域別の世界の緑内障市場の成長機会
• 世界の緑内障市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の緑内障市場の能力拡大
  • 世界の緑内障市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch+Lomb Corporation
• Teva Pharmaceuticals Industries

Glaucoma Trends and Forecast

The future of the global glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global glaucoma market is expected to reach an estimated $12.04 billion by 2030 with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

A more than 150-page report is developed to help in your business decisions.

Glaucoma by Segment

The study includes a forecast for the global glaucoma by disease type, drug class, distribution channel, and region.

Glaucoma Market by Disease Type [Shipment Analysis by Value from 2018 to 2030]:

• Open Angle Glaucoma
• Angle Closure Glaucoma
• Others

Glaucoma Market by Drug Class [Shipment Analysis by Value from 2018 to 2030]:

• Prostaglandins Analogs
• Beta-blockers
• Adrenergic Agonists
• Carbonic Anhydrase Inhibitors
• Others

Glaucoma Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Glaucoma Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Glaucoma Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies glaucoma companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the glaucoma companies profiled in this report include-

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• Abbvie
• Bausch + Lomb Corporation
• Teva Pharmaceuticals Industries

Glaucoma Market Insights

Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications

Features of the Global Glaucoma Market

Market Size Estimates: Glaucoma market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Glaucoma market size by disease type, drug class, distribution channel, and region in terms of value ($B).

Regional Analysis: Glaucoma market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different disease type , drug class , distribution channel , and regions for the glaucoma market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the glaucoma market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the glaucoma market size?

Answer: The global glaucoma market is expected to reach an estimated $12.04 billion by 2030.

Q.2 What is the growth forecast for glaucoma market?

Answer: The global glaucoma market is expected to grow with a CAGR of 7.0% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the glaucoma market?

Answer: The major drivers for this market are increasing glaucoma incidence rates and increasing glaucoma awareness and growing need in the field of ophthalmology for novel treatment strategies.

Q4. What are the major segments for glaucoma market?

Answer: The future of the glaucoma market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.

Q5. Who are the key glaucoma market companies?

Answer: Some of the key glaucoma companies are as follows.

• Pfizer
• Santen Pharmaceutical
• Novartis
• Alcon
• Akron Operating Company
• Thea Pharma
• AbbVie
• Bausch + Lomb Corporation
• Teva Pharmaceuticals Industries
• 0

Q6. Which glaucoma market segment will be the largest in future?

Answer: Lucintel forecasts that open angle glaucoma is expected to witness highest growth over the forecast period due to rising prevalence of age-related eye conditions such sleep apnea, vascular diseases, and blurred vision.

Q7. In glaucoma market, which region is expected to be the largest in next 5 years?

Answer: Asia Pacific is expected to witness highest growth over the forecast period due to advancements in the diagnosis, treatment, and administration of new medications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the glaucoma market by disease type (open angle glaucoma, angle closure glaucoma, and others), drug class (prostaglandins analogs, beta-blockers, adrenergic agonists, carbonic anhydrase inhibitors, and others), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Glaucoma Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Glaucoma Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Glaucoma Market by Disease Type
  • 3.3.1: Open Angle Glaucoma
  • 3.3.2: Angle Closure Glaucoma
  • 3.3.3: Others
• 3.4: Global Glaucoma Market by Drug Class
  • 3.4.1: Prostaglandins Analogs
  • 3.4.2: Beta-blockers
  • 3.4.3: Adrenergic Agonists
  • 3.4.4: Carbonic Anhydrase Inhibitors
  • 3.4.5: Others
• 3.5: Global Glaucoma Market by Distribution Channel
  • 3.5.1: Hospital Pharmacy
  • 3.5.2: Retail Pharmacy
  • 3.5.3: Online Pharmacy

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Glaucoma Market by Region
• 4.2: North American Glaucoma Market
  • 4.2.2: North American Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.3: European Glaucoma Market
  • 4.3.1: European Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.3.2: European Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.4: APAC Glaucoma Market
  • 4.4.1: APAC Glaucoma Market by Disease Type: Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.4.2: APAC Glaucoma Market by Distribution Channe: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
• 4.5: ROW Glaucoma Market
  • 4.5.1: ROW Glaucoma Market by Disease Type : Open Angle Glaucoma, Angle Closure Glaucoma, and Others
  • 4.5.2: ROW Glaucoma Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Glaucoma Market by Disease Type
  • 6.1.2: Growth Opportunities for the Global Glaucoma Market by Drug Class
  • 6.1.3: Growth Opportunities for the Global Glaucoma Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Glaucoma Market by Region
• 6.2: Emerging Trends in the Global Glaucoma Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Glaucoma Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Glaucoma Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Santen Pharmaceutical
• 7.3: Novartis
• 7.4: Alcon
• 7.5: Akron Operating Company
• 7.6: Thea Pharma
• 7.7: AbbVie
• 7.8: Bausch + Lomb Corporation
• 7.9: Teva Pharmaceuticals Industries